Effects/NNS
of/IN
glucocorticoids/NNS
on/IN
lymphocyte/NN
activation/NN
in/IN
patients/NNS
with/IN
steroid-sensitive/JJ
and/CC
steroid-resistant/JJ
asthma/NN
./.

BACKGROUND/NN
:/:
Glucocorticoids/NNS
are/VBP
important/JJ
medications/NNS
used/VBN
to/TO
control/VB
the/DT
airway/NN
inflammation/NN
associated/VBN
with/IN
asthma/NN
./.
=====
Synthetic/JJ
glucocorticoids/NNS
vary/VBP
in/IN
their/PRP$
binding/NN
affinity/NN
for/IN
the/DT
glucocorticoid/NN
receptor/NN
(/(
GCR/NN
)/)
./.
=====
METHODS/NNS
:/:
We/PRP
compared/VBD
hydrocortisone/NN
,/,
beclomethasone/NN
dipropionate/NN
,/,
triamcinolone/NN
acetonide/NN
,/,
flunisolide/NN
,/,
and/CC
budesonide/NN
with/IN
regard/NN
to/TO
their/PRP$
capacity/NN
to/TO
inhibit/VB
phytohemagglutinin-induced/JJ
peripheral/JJ
blood/NN
mononuclear/JJ
cell/NN
proliferation/NN
from/IN
six/CD
patients/NNS
with/IN
steroid-sensitive/JJ
asthma/NN
and/CC
seven/CD
patients/NNS
with/IN
steroid-resistant/JJ
asthma/NN
./.
=====
Peripheral/JJ
blood/NN
mononuclear/JJ
cell/NN
GCR/NN
binding/NN
affinities/NNS
for/IN
dexamethasone/NN
and/CC
budesonide/NN
were/VBD
also/RB
determined/VBN
for/IN
both/DT
patient/NN
groups/NNS
by/IN
using/VBG
a/DT
radioligand/NN
binding/NN
assay/NN
and/CC
Scatchard/NN
analysis/NN
./.
=====
RESULTS/NNS
:/:
Dose-dependent/JJ
inhibition/NN
was/VBD
demonstrated/VBN
for/IN
all/DT
glucocorticoids/NNS
in/IN
both/DT
patient/NN
groups/NNS
,/,
with/IN
the/DT
steroid-resistant/JJ
group/NN
requiring/VBG
approximately/RB
2/CD
log-fold/JJ
more/JJR
glucocorticoids/NNS
for/IN
an/DT
equivalent/JJ
degree/NN
of/IN
inhibition/NN
./.
=====
The/DT
mean/NN
concentrations/NNS
necessary/JJ
to/TO
cause/VB
50/CD
%/NN
inhibition/NN
of/IN
lymphocyte/NN
proliferation/NN
(/(
IC50s/NNS
)/)
for/IN
the/DT
steroid-sensitive/JJ
group/NN
ranged/VBD
from/IN
2/CD
x/CC
10(-10)/CD
mol/L/NN
for/IN
budesonide/NN
to/TO
7/CD
x/CC
10(-8)/CD
mol/L/NN
for/IN
hydrocortisone/NN
,/,
whereas/IN
the/DT
mean/NN
IC50s/NNS
for/IN
the/DT
steroid-resistant/JJ
group/NN
ranged/VBD
from/IN
approximately/RB
2/CD
x/CC
10(-8)/CD
mol/L/NN
for/IN
budesonide/NN
to/TO
greater/JJR
than/IN
10(-6)/CD
mol/L/NN
for/IN
hydrocortisone/NN
./.
=====
In/IN
addition/NN
,/,
a/DT
significant/JJ
correlation/NN
was/VBD
noted/VBN
between/IN
the/DT
degree/NN
of/IN
inhibition/NN
of/IN
lymphocyte/NN
proliferation/NN
(/(
IC50/NN
)/)
and/CC
the/DT
binding/NN
affinity/NN
of/IN
dexamethasone/NN
to/TO
the/DT
GCR/NN
./.
=====
Patients/NNS
with/IN
steroid-resistant/JJ
asthma/NN
have/VBP
been/VBN
shown/VBN
to/TO
have/VB
a/DT
reduced/VBN
GCR/NN
binding/NN
affinity/NN
./.
=====
The/DT
GCR/NN
binding/NN
affinity/NN
for/IN
budesonide/NN
was/VBD
significantly/RB
higher/JJR
in/IN
both/DT
groups/NNS
(/(
i.e./FW
,/,
lower/JJR
dissociation/NN
constant/NN
)/)
than/IN
that/DT
obtained/VBN
for/IN
dexamethasone/NN
./.
=====
CONCLUSION/NN
:/:
These/DT
data/NNS
suggest/VBP
that/IN
glucocorticoids/NNS
such/JJ
as/IN
budesonide/NN
,/,
by/IN
virtue/NN
of/IN
their/PRP$
high/JJ
GCR/NN
binding/NN
affinities/NNS
and/CC
greater/JJR
ability/NN
to/TO
suppress/VB
lymphocyte/NN
proliferation/NN
,/,
may/MD
therefore/RB
be/VB
beneficial/JJ
in/IN
the/DT
management/NN
of/IN
difficult-to-control/JJ
asthma/NN
./.